Current Applications andÂ Advances in Fluorescence Guided Surgery-2016 Leica Webinar

Video Transcription

Video Summary

The video is a webinar titled "Current Applications and Advances in Fluorescence-Guided Surgery" presented by Costas Hadjipanais. The webinar discusses the use of 5-aminolevulinic acid (5-ALA) and fluorescein sodium in fluorescence-guided surgery for brain tumors. 5-ALA is a prodrug that is metabolized by tumor tissue to produce protoporphyrin 9, which fluoresces and can help surgeons visualize tumor tissue during surgery. The webinar covers various topics, including the diagnostic accuracy of fluorescence-guided surgery, the extent of resection studies, patient safety, and the regulatory state of fluorescence-guided surgery in the United States. The webinar also mentions the use of fluorescence-guided surgery for other tumor types, such as spinal cord tumors and meningiomas. The benefits of fluorescence-guided surgery include improved intraoperative visualization of tumors, the ability to visualize tumors in real time, and the potential for more extensive tumor resection. The video concludes by highlighting the ongoing research and potential future developments in the field of fluorescence-guided surgery.

Keywords

Fluorescence-Guided Surgery

5-aminolevulinic acid

Fluorescein sodium

Brain tumors

Protoporphyrin 9

Diagnostic accuracy

Tumor resection

Spinal cord tumors

Meningiomas

Ongoing research